Open Positions On Blog

 

#INFY Future December

#MCX CrudeOil December

#MCX Nickel December

Hold Only For Huge Return..

Pay Now & Join Super Signature HNI Positional Profit Plan, Call

09980555517

Ask Bank Details For Subscriptions If You Have Rs. 50 Lac+++

09900017008

Rollover Positions In December Series Now.. INFY Future

 Given To All As A Live Free Trades>>>>> 

Please Rollover In December Series Now On Immediate Basis

INFY Future November

3 Lots Buy Given At 1129

Now Cmp: 1141

Please Rollover In December Series

Now Cmp: 1145

Now New Costing Will Be 1133

HOLD AS IT IS FOR HUGE RETURN

STILL TARGET 1300+++

Minimum Return / Stocks More Then 25%

 

After Filter Got #Six Stocks Futures 4 U

Now I Can Expect Big Moves In That 6 Stocks Minimum Return / Stocks More Then 25% 5 Lots Each 30 Lots Total Holding.. Minimum Required Capital: Rs. 70 Lac Total Quantity: 55255 Risk Rs. 20 Lac Return Rs. 1.50 Crore Accuracy 100%

My Personal View For TATASTEEL

 

TATASTEEL 

LTP: 533

Expected Upside: 675

Its My Personal View For This Target 675. Buy Recommendations For All The Investors or Traders. Medium Term To Long Term Prospective. All the Fundamentals & Technical Levels Also Providing Indications For Strong Buy. 

For More Details, Call Me

+91 9980555517

Whats App Me

+91 9900017008

My View On ExideInd

 

Exide Industries

LTP: 171.50

Expected Upside: 205

"Exide Industries reported better than expected results as sales/EBITDA/net profit were higher than our forecasts by 11/19/27 percent. We raise FY21 sales/EBITDA/EPS estimates by 6/11/14 percent respectively given better than expected Q2FY21 results. We also raise FY22 estimates by 4/7/9 percent. Our SOTP based target price (based on FY23 earnings) stands at Rs 205". Its My personal view and 100% buy recommendations for all traders or investors. I believe to hold positions from short term to long term. This target is for very short term to mid term period.

For More Details, Call Me

+91 9980555517

Whats App Me

+91 9900017008

My View On A Pharmaceutical Stock That Not Moved Still But Very Soon 🎆🎆🎆🎆🎆🎆🎇🎇🎇🎈🧨🎄🎍🎁

 

Sun Pharmaceutical Industries 

LTP: Rs 503.80

Target price: Rs 618

Expected Upside More Then Written Price

The brokerage believes the US business for Sun Pharma (excluding Taro Pharmaceuticals and Dusa Pharmaceuticals) should start growing as 92 ANDAs (abbreviated new drug applications) and 6 NDAs, which are pending approval, gradually start reflecting in incremental revenues.

Price erosion in base business is unlikely to be painful as the same is now commoditised with a median competitive intensity of eight players across its marketed ANDA portfolio.

In addition to complex ANDAs, Sun Pharma is also aggressively developing value-added generic drugs that are targeting the following segments: 

1) Patients suffering from dysphagia. 

2) Dosing convenience. 

3) Improved health care administration.

The domestic business should deliver a low double-digit growth and outpace the Indian pharmaceutical market driven by its large exposure to the chronic segment. the brokerage said.

For More Details, Call Me

+91 9980555517

Whats App Me

+91 9900017008

#छठपूजा

 Greetings and best wishes on the occasion of #chhathPuja, 

 a festival dedicated to worshiping of Sun God.

May all be blessed with good health, happiness, and prosperity.
#छठपूजा
@arbindtiwariT

Please Rollover Nickel Short Positions In December Series...

 

 Given To All Of You As A Free Live Trades On 14th October 2020

MCX Nickel November

2 Lots Short Sell Given 1139

Now Cmp: 1200

Please Rollover Now In December Series

Now Cmp: 1197

Now Our Costing For 2 Lots Nickel Is Now 1136

HOLD WITHOUT STOPLOSS FOR HUGE RETURN ONLY

SO FOR TIME BEING POSITION OPEN WITHOUT STOPLOSS

Pay Now & Join Super Signature HNI Positional Profit Plan, Call

09980555517

Minimum Return / Stocks More Then 25%

 

After Filter Got #Six Stocks Futures 4 U

Now I Can Expect Big Moves In That 6 Stocks

Minimum Return / Stocks More Then 25%

5 Lots Each

30 Lots Total Holding..

Minimum Required Capital: Rs. 70 Lac

Total Quantity: 55255

Risk Rs. 20 Lac

Return Rs. 1.50 Crore

Accuracy 100%

Call Me Now

09980555517

Ask Details On Whats App

09900017008

You Can Chat On Whats App Also

09980555517

Active HNI Traders Follow Me On My Twitter For Live Trades

https://twitter.com/arbindtiwariT/status/1329478309936128001

Please Rollover All 12 Lots Of CrudeOil

 

Please Rollover All The Lots Of CrudeOil In Next December Series......

MCX CrudeOil November

6 Lots Bought At 4388

6 Lots Bought At 3418

Average Cost For All 12 Lots Is 3903

Now Cmp: 3080

Rollover All 12 Lots Of Crudeoil In December Series

Now Cmp: 3103

New Costing For All 12 Lots Will be 3926

Hold All As It Is For Best Return..

Pay Now & Join Super Signature ``HNI PROFIT PLAN``, Call

09980555517

Ask Bank Details For Subscriptions

09900017008

Dipawali Muhurat Trading Call For Investment

BankBaroda Future November Buy 3 Lots At 46.90 Now Cmp: 46.90 HOLD FOR TARGET 100... Cash Or Future .. You Can Decide..

Investment Call Hold For 1-2 Year Minimum

Happy Dipawali Once Again To All Of You

Thanks & Regards

Aarbind Tiwari

Independent Market Analyst

Twitter Id @arbindtiwariT

Blog For Free Trial:  https://arbindtiwaripositional-intradaytrades.blogspot.com 

Contact No: +91 9980555517

What`s App: +91 9900017008

Telegram: +91 9980555517

Wish You All Happy DHANTERAS

 

Is it Time to Look at Mid-and-Small Cap Stocks after FM’s Stimulus Speech?

 

India’s two main indices, Nifty and BSE Sensex, didn’t pay heed to the stimulus package, Atmanirbhar 3.0, announced by Finance Minister N Sitharaman. The Sensex dropped 0.54% while Nifty lost 0.46%.

Market analysts are divided on the reason why: Either the market has taken the stimulus into account already or today was a day of profit booking and the market will resume its rally soon.

However, while the Sensex and Nifty dropped, the NIFTY Midcap 100 index was up by 0.41% and the NIFTY Smallcap 100 was up by 1.31%. As the FM announced measures for the MSME segment that gave a lot more clarity to the mid and small-cap stocks on the government’s efforts to support the companies in the space and increase investments. Some of the measures that will provide to the sector include:

1. A fertilizer subsidy of Rs. 65,000 crore to farmers.
2. An additional outlay of Rs. 18,000 crore Pradhan Mantri Awas Yojana (Urban) that will help start work on 12 lakh houses and complete 18 lakh houses.
3. Extension of the Emergency Credit Loan Guarantee Scheme(ECLGS) until March 31, 2021.
4. An additional outlay of Rs 10,000 crore for PM Garib Kalyan Yojana.
5. A new job creation scheme that subsidizes firms who hire new employees. The subsidy covers retirement fund contributions by employees as well as employers for two years.

NCC Consolidated September 2020 Net Sales at Rs 1,708.32 crore, down 11.86% Y-o-Y

 

Reported Consolidated quarterly numbers for NCC are:

Net Sales at Rs 1,708.32 crore in September 2020 down 11.86% from Rs. 1,938.28 crore in September 2019.

Quarterly Net Profit at Rs. 64.60 crore in September 2020 down 21.39% from Rs. 82.18 crore in September 2019.

EBITDA stands at Rs. 267.69 crore in September 2020 down 15.85% from Rs. 318.10 crore in September 2019.

NCC EPS has decreased to Rs. 1.06 in September 2020 from Rs. 1.37 in September 2019.

NCC shares closed at 36.10 on November 10, 2020 (NSE) and has given 53.62% returns over the last 6 months and -37.44% over the last 12 months.

NCC Consolidated Quarterly Results in Rs. Cr.

Sep'20 Jun'20 Sep'19 Net Sales/Income from operations 1,708.32 1,297.60 1,938.28 Other Operating Income -- -- -- Total Income From Operations 1,708.32 1,297.60 1,938.28 EXPENDITURE Consumption of Raw Materials 487.87 415.98 612.58 Purchase of Traded Goods -- -- -- Increase/Decrease in Stocks 14.75 3.09 20.28 Power & Fuel -- -- -- Employees Cost 91.42 95.24 126.32 Depreciation 45.48 45.82 51.75 Excise Duty -- -- -- Admin. And Selling Expenses -- -- -- R & D Expenses -- -- -- Provisions And Contingencies -- -- -- Exp. Capitalised -- -- -- Other Expenses 881.86 658.47 920.97 P/L Before Other Inc., Int., Excpt. Items & Tax 186.94 79.00 206.38 Other Income 35.27 31.11 59.97 P/L Before Int., Excpt. Items & Tax 222.21 110.11 266.35 Interest 122.88 122.01 140.62 P/L Before Exceptional Items & Tax 99.33 -11.90 125.73 Exceptional Items -- -- -13.91 P/L Before Tax 99.33 -11.90 111.82 Tax 29.59 -28.98 31.03 P/L After Tax from Ordinary Activities 69.74 17.08 80.79 Prior Year Adjustments -- -- -- Extra Ordinary Items -- -- -- Net Profit/(Loss) For the Period 69.74 17.08 80.79 Minority Interest -5.10 -1.33 3.40 Share Of P/L Of Associates -0.04 -0.07 -2.01 Net P/L After M.I & Associates 64.60 15.68 82.18 Equity Share Capital 121.97 121.97 120.13 Reserves Excluding Revaluation Reserves -- -- -- Equity Dividend Rate (%) -- -- -- EPS Before Extra Ordinary Basic EPS 1.06 0.26 1.37 Diluted EPS 1.06 0.26 1.37 EPS After Extra Ordinary Basic EPS 1.06 0.26 1.37 Diluted EPS 1.06 0.26 1.37 Public Share Holding No Of Shares (Crores) -- -- -- Share Holding (%) -- -- -- Promoters and Promoter Group Shareholding a) Pledged/Encumbered - Number of shares (Crores) -- -- -- - Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- - Per. of shares (as a % of the total Share Cap. of the company) -- -- -- b) Non-encumbered - Number of shares (Crores) -- -- -- - Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- - Per. of shares (as a % of the total Share Cap. of the company) -- -- -- Source : Dion Global Solutions Limited